APPL1 and Insulin resistance: Hematopoietic-specific deletion of APPL1 aggravated HFD-induced glucose intolerance and insulin resistance, as assessed by glucose tolerance test (GTT) and insulin tolerance test (ITT), respectively (Supplementary Fig. 10).